AstraZeneca’s Soliris® Is Approved in Malaysia for Treatment of Rare Neurological Autoimmune Diseases and Severe Blood Disorders
AstraZeneca, a global, science-led biopharmaceutical company, has made available its treatment, Soliris®, in Malaysia as part of its ongoing commitment to support patients living with rare disease worldwide. Soliris® marks…